Skip to content

Comprehensive cognitive and physical function assessment and develpoed severity scoring model for patients with sarcopenia

Comparison of physical and cognitive function between normal adult and patient with sarcopenia, and development of pathophysiological model for severity stratification in Sarcopenia patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008867
Enrollment
600
Registered
2023-10-12
Start date
2023-09-07
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

InBody
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Adult men and women over 50 years of age -Able to walk independently - Those who understand the explanation of this study and agree to participate

Exclusion criteria

Exclusion criteria: ? People with neurological diseases that affect walking (e.g., traumatic brain injury (TBI), stroke, multiple sclerosis) ? Those who have undergone orthopedic surgery within the last 6 months or have had a central fracture (central bone: spine, pelvis, lower extremity) within 1 year ? Liver level (more than 3 times the upper normal limit) ? Those with abnormalities in kidney function (eGFR 1.2) ? Chronic disease patients (a) Type 1 diabetes or uncontrolled type 2 diabetes (fasting blood sugar = 160mg/dl), (b) Uncontrolled hypertension (>160/100 mmHg), (c) heart failure (NYHA class 3,4), (d) chronic obstructive pulmonary disease (COPD, grade C, D), (e) Those with liver cirrhosis (Child-Pugh B, C) ? Those who have been diagnosed with cancer requiring treatment within the last 5 years ? Those who are unable to measure grip strength and lower extremity strength ? Persons with cognitive decline to the point where they cannot follow instructions ? Any other person who is unable to participate in the study at the discretion of the PI (principal investigator)

Design outcomes

Primary

MeasureTime frame
Skeletal Muscle Index (SMI)

Secondary

MeasureTime frame
gait speed ;five times sit to stand test (FTST);Timed up and go (TUG);Low extremity muscle strength;MVC amplitude of Quadriceps muscle surface EMG ;Korean version of SARC-F ;Korean version of Patient Health Questionnaire-9(PHQ-9);Korean version of EuroQol-5 Dimension(EQ-5D-5L);Korean Version of Montreal Cognitive Assessment (MoCA-K);coding of Koren Wechsler Adult Intelligence Scale-4 evaluation items(K-WAIS-4; coding) ;Cogscreen, EmoCog® (Smartphone App embedded cognitive function assessent tool);hand grip strength;step length ;Double limb support time ;PDT, EmoCog® (Smartphone App. embedded neurodegenerative disease screening tool)

Countries

Korea, Republic of

Contacts

Public ContactKyoung Tae Kim

Keimyung University Dongsan Hospital

zealot42@naver.com+82-53-258-7692

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026